{
    "2015-05-15": [
        "Tim Anderson sees Merck coming out of SGLT2 safety woes with stronger Januvia sales.",
        "View today's #Pharma Daily News Round-Up Video: Takeda, AMG 334, Actavis, Cynviloq"
    ]
}